PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease
Abstract
Authors
N. Madkour M. Bounthavong D.I. Hsu
N. Madkour M. Bounthavong D.I. Hsu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now